Bioxis

Based in France, Bioxis specializes in the discovery, development, production and commercialization of innovative regenerative medicine products. Through groundbreaking solutions, the company develops popular products that help doctors improve quality of care. Their lead medical device candidate MTI-12 is currently at the pre-clinical stage for aesthetic indications; and their hyaluronic acid-based dermal filler brand, CYTOSIAL, has established into exclusive distribution agreements with distributors in Europe and Asia.